
Dr. Rebecca Baergen received her medical degree from the University of California at Los Angeles and completed her residency training in pathology at the Los Angeles County Harbor-UCLA Medical Center. Dr. Baergen was a member of the faculty of the University of California at San Diego until she came to the Weill Medical College of Cornell University in 1997. Dr. Baergen trained with one of the pioneers in placental and perinatal pathology, Dr. Kurt Benirschke. Dr. Baergen has lectured and published extensively in this field and her special interests include the pathogenesis of fetal demise, fetal growth restriction, placental malperfusion, maternal thrombophilias, fetal vascular thrombosis and abnormalities of the umbilical cord.
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study.
Releasing Placentas to Families: A Unified Recommendation From the Perinatal Committee of the Society for Pediatric Pathology.
Neonatologist responsibility to ensure placentas are received for pathologic examination-response to comment on criteria for placental examination for obstetric and neonatal providers.